13F Filings History of Endurant Capital Management LP
- Latest 13F filing
- Q4 2023 - 14 Feb 2024
- Latest reported 13F value
- $0
- Largest 13F holdings
-
BSX TMO AXNX ELV ICLR LH EHC PODD HOLX ZBH AVTR THC
+8 more
PFE BMRN KIDS CI QDEL COO SBRA A - Form 13F summary
-
- Endurant Capital Management LP Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- Endurant Capital Management LP reported 25 equity holdings with a total reported market value of $17,441,623 for Q4 2023. Top reported holdings included BSX, TMO, AXNX, ELV, and ICLR.
- Manager signature
- Chris Ronan - Chief Compliance Officer
- Manager location
- San Mateo, CA
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Endurant Capital Management LP with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q4 2023
Latest value
$17,441,623
Quarter delta
$0
Accepted
14 Feb 2024, 16:01
Rows shown
1-25 of 38
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | $0 | -$17,441,623 | -$17,441,623 | 13F-HR | 07 May 2024, 11:09 | |
| Q4 2023 | 25 | $17,441,623 | +$5,692,797 | -$104,470,134 | -$98,777,337 | BSX, TMO, AXNX, ELV, ICLR | 13F-HR | 14 Feb 2024, 16:01 |
| Q3 2023 | 43 | $111,347,011 | +$81,404,066 | -$44,792,821 | +$36,611,245 | BMRN, TMO, BRKR, AZN, ELV | 13F-HR | 14 Nov 2023, 16:01 |
| Q2 2023 | 30 | $77,586,085 | +$24,232,840 | -$142,982,459 | -$118,749,619 | LH, CI, MRK, A, THC | 13F-HR | 14 Aug 2023, 16:00 |
| Q1 2023 | 49 | $194,666,407 | +$100,814,341 | -$149,637,993 | -$48,823,652 | BMRN, BDX, ELV, SBRA, LH | 13F-HR | 15 May 2023, 16:02 |
| Q4 2022 | 55 | $246,253,014 | +$80,967,440 | -$146,645,883 | -$65,678,443 | INVACARE CORP, LH, CI, MRK, CNC | 13F-HR | 14 Feb 2023, 16:01 |
| Q3 2022 | 49 | $307,049,000 | +$140,853,717 | -$82,784,089 | +$58,069,628 | INVACARE CORP, LH, HUM, TAK, BAX | 13F-HR | 14 Nov 2022, 16:03 |
| Q2 2022 | 47 | $262,192,000 | +$93,818,727 | -$144,731,988 | -$50,913,261 | INVACARE CORP, QGEN, BSX, AVTR, HUM | 13F-HR | 15 Aug 2022, 16:09 |
| Q1 2022 | 60 | $331,322,000 | +$124,045,567 | -$141,730,235 | -$17,684,668 | INVACARE CORP, CNC, LH, AZN, BMY | 13F-HR | 16 May 2022, 16:01 |
| Q4 2021 | 64 | $369,846,000 | +$214,533,943 | -$180,180,484 | +$34,353,459 | INVACARE CORP, SNY, LH, AZN, SIBN | 13F-HR | 14 Feb 2022, 16:00 |
| Q3 2021 | 51 | $328,678,000 | +$159,030,895 | -$176,118,134 | -$17,087,239 | INVACARE CORP, ABBV, HUM, JNJ, HOLX | 13F-HR | 15 Nov 2021, 16:01 |
| Q2 2021 | 57 | $363,842,000 | +$190,554,059 | -$184,871,796 | +$5,682,263 | INVACARE CORP, LH, CI, ICLR, TMO | Restatement | 27 Aug 2021, 11:44 |
| Q1 2021 | 60 | $368,298,000 | +$195,269,477 | -$134,538,961 | +$60,730,516 | KIDS, INVACARE CORP, BMY, AHCO, SNY | 13F-HR | 17 May 2021, 15:49 |
| Q4 2020 | 52 | $277,286,000 | +$107,861,845 | -$179,674,901 | -$71,813,056 | OXFD, BDX, BMY, TRILLIUM THERAPEUTICS INC, ABBV | 13F-HR | 16 Feb 2021, 15:14 |
| Q3 2020 | 57 | $289,530,000 | +$144,860,481 | -$107,061,614 | +$37,798,867 | BMY, OXFD, EHC, ABBV, IART | 13F-HR | 16 Nov 2020, 16:11 |
| Q2 2020 | 54 | $245,145,000 | +$117,636,760 | -$133,919,924 | -$16,283,164 | OXFD, EVOLENT HEALTH INC, SIBN, JNJ, CNC | 13F-HR | 14 Aug 2020, 16:13 |
| Q1 2020 | 51 | $220,672,000 | +$120,264,294 | -$149,875,433 | -$29,611,139 | SNY, PFE, HOLX, SIBN, OXFD | 13F-HR | 15 May 2020, 16:03 |
| Q4 2019 | 51 | $301,967,945 | +$149,382,650 | -$1,620,974,112 | -$1,471,591,462 | BMY, ELV, ZBH, OXFD, COR | 13F-HR | 14 Feb 2020, 16:06 |
| Q3 2019 | 48 | $251,024,000 | +$129,433,656 | -$112,395,474 | +$17,038,182 | RCM, ZBH, HCA, OXFD, LH | Restatement | 25 Nov 2019, 16:37 |
| Q2 2019 | 50 | $253,641,000 | +$127,861,502 | -$109,365,381 | +$18,496,121 | TAK, LH, ZBH, WMGI, RCM | 13F-HR | 14 Aug 2019, 16:07 |
| Q1 2019 | 65 | $235,341,000 | +$161,929,504 | -$126,461,252 | +$35,468,252 | BMY, IIN, ICLR, VCRA, CI | 13F-HR | 15 May 2019, 16:05 |
| Q4 2018 | 48 | $189,197,000 | +$94,388,145 | -$105,930,621 | -$11,542,476 | AGN, CI, ZBH, CELG, CVS | 13F-HR | 14 Feb 2019, 16:04 |
| Q3 2018 | 73 | $224,793,000 | +$85,770,335 | -$115,124,438 | -$29,354,103 | CI, SHPG, AGN, TVTY, WMGI | 13F-HR | 14 Nov 2018, 16:07 |
| Q2 2018 | 65 | $230,616,000 | +$55,190,993 | -$104,872,360 | -$49,681,367 | AGN, MRK, ABT, SHPG, CI | 13F-HR | 14 Aug 2018, 16:09 |
| Q1 2018 | 69 | $267,700,000 | +$91,249,501 | -$143,331,784 | -$52,082,283 | AGN, ABT, JNJ, MDT, BDX | 13F-HR | 15 May 2018, 16:06 |